可转向入路装置用于EUS引导胆道引流的初步临床经验
本研究在3家三级学术医院回顾性分析22例ERC失败后接受EUS-BD并使用可转向入路装置的患者,评估安全性与技术可行性。结果显示穿刺和导线定向推进均100%成功,技术成功率95%,不良事件率4.5%(1例轻度胰腺炎),无胆漏、出血或30天死亡。
要点
- 可转向入路装置在EUS-BD中穿刺和导线定向推进均100%成功(22/22)。
- 技术成功率为95%(21/22),不良事件率4.5%(1例轻度胰腺炎)。
- 无导线剪切、胆漏、出血或30天死亡病例。
核心结论
- 该可转向入路系统用于EUS-BD的首次临床经验提示其安全有效,尤其在控制导线推进方向方面。
研究设计与样本
- 回顾性研究,采用前瞻性采集数据,在3家三级学术医院纳入连续ERC失败后接受EUS-BD并使用该入路装置的患者,共22例。
主要发现
- 穿刺和导线沿预期方向选择性推进均100%成功(22/22)。
- 技术成功率为95%(21/22)。
- 无导线剪切病例,不良事件率4.5%(1例轻度胰腺炎),30天随访无胆漏、出血或死亡。
关键数值与推荐
- 主要结局为安全性和技术可行性(EUS-BD成功完成)。
- 临床成功定义为30天时肝功能检查改善75%。
临床怎么用
- 对于ERC失败后需行EUS-BD的患者,该可转向入路装置可用于穿刺后定向控制导线推进。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: EUS-guided biliary drainage (EUS-BD) has been used as a rescue procedure after failed endoscopic retrograde cholangiography (ERC), and there is growing interest in EUS-BD as a primary therapy for distal malignant biliary obstruction. After EUS-guided needle puncture of an obstructed bile duct, directional control of wire advancement remains an area of need, potentially addressed by a new steerable EUS access system. The aim of this study was to evaluate the safety and efficacy of this novel steerable access system in patients undergoing EUS-BD after failed ERC. METHODS: We performed a retrospective study of prospectively acquired data at 3 tertiary academic hospitals. Consecutive patients who had failed ERC followed by EUS-BD using the access device were included. Primary outcomes were safety and technical feasibility (successful completion of EUS-BD). Secondary outcomes were clinical success (75% improvement in liver function tests at 30 days) and device performance. RESULTS: Twenty-two consecutive patients underwent EUS-BD between October 10, 2018 and March 3, 2019. Needle puncture and selective wire advancement in the intended direction were both successful in 100% of cases (22/22). Technical success was 95% (21/22). Fifty-nine percent (13) underwent rendezvous, 32% (7) underwent choledochoduodenostomy, and 4.5% (1) underwent hepaticogastrostomy. One patient (4.5%) underwent percutaneous transhepatic cholangiography. There were no cases of wire shearing. The adverse event rate was 4.5% (mild pancreatitis in 1 patient). There was no bile leak, bleeding, or death at 30 days' follow-up. CONCLUSIONS: This first clinical experience with a steerable access system for EUS-BD suggests it is safe and effective, particularly with regard to controlling direction of wire advancement.
引用
- Ryou M, Benias PC, Kumbhari V, et al. Initial clinical experience of a steerable access device for EUS-guided biliary drainage. Gastrointest Endosc. 2019. PMID: 31408653. doi:10.1016/j.gie.2019.07.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。